No evidence of skin blisters with human desmocollin-3 gene mutation.

To the editor: Ayub et al.1xA homozygous nonsense mutation in the human desmocollin-3 (DSC3) gene underlies hereditary hypotrichosis and recurrent skin vesicles. Ayub, M., Basit, S., Jelani, M., Ur Rehman, F., Iqbal, M., Yasinzai, M., and Ahmad, W. Am. J. Hum. Genet. 2009; 85: 515–520Abstract | Full Text | Full Text PDF | PubMed | Scopus (45)See all References1 recently reported that a homozygous nonsense mutation (c.2129T>G [p.Leu710X]) in the human desmocollin-3 (DSC3) gene underlies hereditary hypotrichosis and recurrent skin vesicles. The publication is of great interest, because this is potentially the first pathophysiologic role for desmocollin-3 in human genetic disease. However, there is no clinical or histologic data shown to document the presence of skin vesicles in affected patients. The clinical photograph (Figure 2C in Ayub et al.1xA homozygous nonsense mutation in the human desmocollin-3 (DSC3) gene underlies hereditary hypotrichosis and recurrent skin vesicles. Ayub, M., Basit, S., Jelani, M., Ur Rehman, F., Iqbal, M., Yasinzai, M., and Ahmad, W. Am. J. Hum. Genet. 2009; 85: 515–520Abstract | Full Text | Full Text PDF | PubMed | Scopus (45)See all References1) does not show skin vesicles but instead appears consistent with a different skin disorder known as keratosis pilaris, which is associated with follicular plugging on histology. In support of this diagnosis, the scalp-skin biopsy (Figure 2D in Ayub et al.1xA homozygous nonsense mutation in the human desmocollin-3 (DSC3) gene underlies hereditary hypotrichosis and recurrent skin vesicles. Ayub, M., Basit, S., Jelani, M., Ur Rehman, F., Iqbal, M., Yasinzai, M., and Ahmad, W. Am. J. Hum. Genet. 2009; 85: 515–520Abstract | Full Text | Full Text PDF | PubMed | Scopus (45)See all References1) shows follicular plugging, but no evidence of blistering. Because keratosis pilaris is a common disorder (affecting up to 40% of the adult population), further studies would be necessary to conclude that DSC3 gene mutations cause an epidermal phenotype in affected patients.The nonsense mutation in DSC3 is predicted to occur at the junction of the transmembrane and cytoplasmic domains, which the authors predict will lead to nonsense-mediated decay of the truncated protein. It remains unknown, however, whether truncated desmocollin-3 protein is expressed in patient skin. Previous studies in mice have shown that targeted deletion of desmocollin-1 causes superficial blistering and abnormal differentiation,2xMice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiation. Chidgey, M., Brakebusch, C., Gustafsson, E., Cruchley, A., Hail, C., Kirk, S., Merritt, A., North, A., Tselepis, C., Hewitt, J. et al. J. Cell Biol. 2001; 155: 821–832Crossref | PubMed | Scopus (113)See all References2 whereas a truncated desmocollin-1 protein lacking most of the cytoplasmic domain incorporates into desmosomes but does not cause an epidermal phenotype.3xAssessment of splice variant-specific functions of desmocollin 1 in the skin. Cheng, X., Mihindukulasuriya, K., Den, Z., Kowalczyk, A.P., Calkins, C.C., Ishiko, A., Shimizu, A., and Koch, P.J. Mol. Cell. Biol. 2004; 24: 154–163Crossref | PubMed | Scopus (21)See all References3 If truncated protein is expressed in human skin, this may identify a pathologic role for the mutant protein in hair follicle development, perhaps distinct from its role in epidermal adhesion.